glutathione and multiple myeloma Targeting metabolism: How abnormal metabolism contributes to myeloma progression resistance to proteasome inhibitors A recent editorial describes the

A recent editorial describes the science behind a study of mezigdomide, which augments the degradation of the proteins Ikaros and Aiolos, to treat multiple myeloma. Panel A shows the chemical structures Frontiers Multiple myeloma metabolism a treasure trove of therapeutic targets? Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy ACS Omega About Multiple Myeloma UCSF Helen Diller Family Comprehensive Cancer Center

SKU: 24871798130 · From iglepidom.org